Schizophrenia (including Schizoaffective disorder), Cancer Schizophrenia, Cancer
Conditions
Interventions
The target of the intervention is the participating psychiatric hospitals/psychiatric care providers. To enable participating hospitals to provide case management to encourage patients to undergo canc
D004517
Education, Professional
Sponsors
Fujiwara Masaki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [Inclusion criteria for participating hospitals] (1) Any psychiatric hospital where written consent for participation in the study can be obtained from the facility director or the head of the outpatient department. [Inclusion criteria for psychiatric care providers to be interviewed] (1) Those who is judged by the facility director or the head of the outpatient department to be involved in cancer screening recommendations and appropriate to participate in the interview. (2) Those who has given consent to participate in the study.
Exclusion criteria
Exclusion criteria: [Exclusion criteria for participating hospitals] (1) Hospitals that have expressed their refusal to participate in the study. [Exclusion criteria for psychiatric care providers to be interviewed] (1) Those who have expressed their refusal to participate in the interview. (2) Those who are judged inappropriate to participate by the director of the facility or the head of the outpatient department for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients who received case management to encourage participation in cancer screening in FY2022 | — |
Secondary
| Measure | Time frame |
|---|---|
| Colorectal cancer screening rate in FY2021 and FY2023 (*evaluated in some patients with consent) Potential barriers and facilitators in implementing the case management to encourage participation in cancer screening The proportion of patients who received a simple recommendation using flyers in FY2023 Description of the process of implementing the intervention in the participating facilities The proportion of patients receiving cancer screenings (colorectal, lung, gastric, breast, and cervical cancer screening), proportion of patients requiring close examination, and proportion of patients receiving close examination in FY2019-FY2026 (*evaluated in some patients with consent) | — |
Contacts
Public ContactMasaki Fujiwara
Department of Neuropsychiatry, Okayama University Hospital
Outcome results
None listed